glutamine has been researched along with Acute Chest Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jonassaint, CR; Kane-Gill, SL; Newman, TV; Novelli, EM; Suh, K; Yang, J | 1 |
| Howell, CM; Monus, T | 1 |
| Akhter, R; Ali, SI; Khan, A | 1 |
1 review(s) available for glutamine and Acute Chest Syndrome
| Article | Year |
|---|---|
Current and emerging treatments for sickle cell disease.
Topics: Acute Chest Syndrome; Acute Disease; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Bacterial Agents; Antisickling Agents; Chronic Disease; Disease Progression; Erythrocyte Transfusion; Fluid Therapy; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Infection Control; Infections; Mesenteric Ischemia; Neonatal Screening; Oxygen Inhalation Therapy; Pain Management; Patient Education as Topic; Pneumococcal Infections; Pneumococcal Vaccines; Stroke | 2019 |
2 other study(ies) available for glutamine and Acute Chest Syndrome
| Article | Year |
|---|---|
Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
Topics: Acute Chest Syndrome; Adult; Anemia, Sickle Cell; Child; Cross-Sectional Studies; Female; Glutamine; Humans; Hydroxyurea; Inpatients; Male | 2023 |
L-Glutamine approved for use in patients with sickle cell disease.
Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Drug Approval; Glutamine; Hospitalization; Humans | 2018 |